Hercules Capital Inc (HTGC)

Form 8-K - Current report

Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.

- Up to $125 million in additional borrowing capacity provides further strategic flexibility - - $50 million...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

NYHTGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Hercules Capital, Inc. Securities Lawsuit - Contact The Gross Law Firm

NYHTGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Hercules Capital, Inc...

Hercules Capital, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - HTGC

Hercules Capital, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - HTGC PR Newswire LOS ANGELES...

HTGC UPCOMING DEADLINE : The Gross Law Firm Alerts Hercules Capital, Inc. Stockholders of Securities Class Action - Contact the Firm

HTGC UPCOMING DEADLINE : The Gross Law Firm Alerts Hercules Capital, Inc. Stockholders of Securities Class...

HTGC Lawsuit Alleges CEO Allegedly Certified Misleading Statements - Hercules Capital Investors Face Losses Following CEO Allegedly Certified Misleading Statements: SueWallSt

HTGC Lawsuit Alleges CEO Allegedly Certified Misleading Statements - Hercules Capital Investors Face Losses...

Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders

Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), will conduct its 2026 Annual Meeting of Stockholders by...

Form 8-K - Current report

Hercules Capital Reports First Quarter 2026 Financial Results

Record Q1 2026 Total New Debt and Equity Commitments of $1.81 Billion, an Increase of 77.8% Year-over-Year Q1 2026 Total Fundings of $706.4...

HTGC Shareholder Alert: Hercules Capital, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm

HTGC Shareholder Alert: Hercules Capital, Inc. Securities Class Action Lawsuit - Investors Should Contact The...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital

THE WOODLANDS, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced...